
🚨 Major shift: @AmericanCancer now directly recommends routine PSA screening for #prostatecancer, moving off pure shared decision-making 🚨 @CACancerJournal 📋 Average risk: PSA every 2 yrs, ages 50-69 📋 High risk (Black men; first-degree relative dx <65 or multiple at any age): annual PSA, ages 45-69 📋 Non-Black w/ one first-degree relative dx ≥65: every 2 yrs, ages 45-69 🔬 Age-adjusted elevated = PSA ≥3.0 (ages 45-69) or ≥6.5 (70-74); repeat in 2 wks to 3 mo, then MRI and/or validated biomarker before biopsy 🛑 70-74 individualized; not recommended ≥75 or if life expectancy <10 yrs ⚠️ Still requires informed consent on benefits, limits, and harms, and departs from USPSTF’s grade C for 55-69 🎯 ACS has moved from “discuss it” to “do it” for average-risk men 50-69 and high-risk men from 45, its biggest change since 2010 🔗 doi.org/10.3322/caac.70112 @UroOnc @urotoday @UrologyTimes @PCF_Science @AmerUrological










































